Ophelia
Medication & support to beat opioid addiction from home
About the Company
Ophelia is a venture-backed healthcare startup that helps people quit opioids and restore quality of life without going to rehab. We make medical best practices discreet, convenient, and affordable – offering FDA-approved medication, support, and therapy through in-person and telehealth modalities. Our mission is to re-invent the drug rehab industry using evidence-based medicine (MAT/MOUD), technology, and a commitment to patient privacy and choice.
For context: opioid overdose is the #1 cause of death for Americans under 50, but 80% of 3 million Americans with opioid use disorder (OUD) are not getting treatment. Most have jobs, families, and privacy concerns, making it easier to get withdrawal medication from a drug dealer than go to rehab. Meanwhile, 2/3rds of rehabs do not offer medication at all, leading 90% of patients to relapse in the first 3 months. As a result of inadequate access to proven treatment, an American dies of an opioid overdose every 11 minutes.
We are a team of world-renowned doctors, scientists, startup veterans, and White House advisors, backed by leading technology and healthcare investors (Y Combinator, General Catalyst) to re-imagine and re-build addiction treatment in America.
Join us, save lives, and help fix healthcare for those who need it most.
Tech Stack
React, node, firebase, GCP
Founders
Mattan is an award-winning faculty member at Columbia Business School and a two-time Y Combinator-backed entrepreneur. He co-founded Ophelia, a company that helps people quit opioids without having to go to rehab. Mattan is also an Innovation Fellow at the Lang Center for Entrepreneurship at Columbia Business School and was selected as one of Forbes' 30 Under 30 in Education. I studied Philosophy and Finance at New York University and wrote my thesis on the metaphysics of consciousness.
Open Positions at Ophelia (3 Jobs)
Ready to start your space career at Ophelia?
